Hikma Pharmaceuticals announce an interim dividend of 25 cents per share, up 32%

DividendMax Ltd.

Hikma Pharmaceuticals announce an interim dividend of 25 cents per share, up 32%

The Himka Board is recommending an interim dividend of 25 cents per share (H1 2022: 19 cents per share). The interim dividend will be paid on 15 September 2023 to eligible shareholders on the register at the close of business on 11 August 2023.Group revenue up 18% with strong growth in all three business segments.

Other financial highlights include:

Reported gross margin of 50.1%, reflecting favourable product mix

Core operating profit up 35% to $401 million, reflecting H1 weighting of Generics and Branded

Good net cash inflow from operating activities, up 31% to $222 million

Robust balance sheet with net debt to core EBITDA5 of 1.3x at 30 June 2023 (31 December 2022 1.5x)

Companies mentioned